Undifferentiated Pleomorphic Sarcoma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Undifferentiated Pleomorphic Sarcoma (UPS) is a rare and aggressive type of sarcoma that can originate in any body part, including soft tissue and bone. The most common sites of involvement are the lower extremities, particularly the thigh, upper arms, retroperitoneum, viscera, head, and neck (in childhood cases). High local recurrence rates and significant metastasis typically characterize it. Symptoms of UPS may include swelling, mass, pain, pathological fractures, and systemic features such as anorexia, malaise, fever, and weight loss. The tumor is diagnosed in individuals between 60 and 70. Treatment for UPS typically involves wide surgical excision, radiation, and sometimes amputation. Adjuvant radiotherapy is often given for high-grade, large, deep-seated tumors, in limb-sparing surgeries, and when negative margins are not obtained. The overall 5-year survival rate for UPS ranges from 48% for patients with head and neck tumors to 77% for patients with tumors arising on th...